These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 12235087)

  • 1. Fatal hepatitis B reactivation following discontinuation of nucleoside analogues for chronic hepatitis B.
    Lim SG; Wai CT; Rajnakova A; Kajiji T; Guan R
    Gut; 2002 Oct; 51(4):597-9. PubMed ID: 12235087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The sequential occurrence of viral mutations in a liver transplant recipient re-infected with hepatitis B: hepatitis B immune globulin escape, famciclovir non-response, followed by lamivudine resistance resulting in graft loss.
    de Man RA; Bartholomeusz AI; Niesters HG; Zondervan PE; Locarnini SA
    J Hepatol; 1998 Oct; 29(4):669-75. PubMed ID: 9824278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamivudine and Famciclovir resistant hepatitis B virus associated with fatal hepatic failure.
    Ayres A; Bartholomeusz A; Lau G; Lam KC; Lee JY; Locarnini S
    J Clin Virol; 2003 May; 27(1):111-6. PubMed ID: 12727536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of lamivudine for the treatment of hepatitis B virus infection after liver transplantation in children.
    Shapira R; Mor E; Bar-Nathan N; Sokal EM; Tur-Kaspa R; Dinari G; Ben-Ari Z
    Transplantation; 2001 Jul; 72(2):333-6. PubMed ID: 11477362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential combination therapy of HBe antigen-negative/virus-DNA-positive chronic hepatitis B with famciclovir or lamivudine and interferon-alpha-2a.
    Schiefke I; Klecker C; Maier M; Oesen U; Etzrodt G; Tannapfel A; Liebert UG; Berr F
    Liver Int; 2004 Apr; 24(2):98-104. PubMed ID: 15078472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral combination therapy for lamivudine-resistant hepatitis B reinfection after liver transplantation.
    Seehofer D; Rayes N; Neuhaus R; Berg T; Müller AR; Bechstein WO; Neuhaus P
    Transpl Int; 2000; 13 Suppl 1():S359-62. PubMed ID: 11112032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral dynamics in chronic hepatitis B patients treated with lamivudine, lamivudine-famciclovir or lamivudine-ganciclovir.
    Wolters LM; Hansen BE; Niesters HG; de Man RA
    Eur J Gastroenterol Hepatol; 2002 Sep; 14(9):1007-11. PubMed ID: 12352221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of recurrent hepatitis B infection after liver transplantation. A retrospective analysis of 200 liver transplantations based on hepatitis B associated liver diseases].
    Seehofer D; Rayes N; Bechstein WO; Naumann U; Neuhaus R; Berg T; Hopf U; Langrehr JM; Steinmüller T; Platz KP; Müller AR; Neuhaus P
    Z Gastroenterol; 2000 Sep; 38(9):773-83. PubMed ID: 11072673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disappearance of hepatitis B virus core deletion mutants and successful combined kidney/liver transplantation in a patient treated with lamivudine.
    Meisel H; Preikschat P; Reinke P; Hocher B; Budde K; Bechstein WO; Neuhaus P; Krüger DH; Neumayer HH
    Transpl Int; 1999; 12(4):283-7. PubMed ID: 10460876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleoside analogues for chronic hepatitis B: antiviral efficacy and viral resistance.
    Papatheodoridis GV; Dimou E; Papadimitropoulos V
    Am J Gastroenterol; 2002 Jul; 97(7):1618-28. PubMed ID: 12135009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of hepatitis B virus variants resistant to lamivudine and famciclovir among randomly selected chronic carriers from Spain.
    León P; Pozo F; Echevarría JM
    Enferm Infecc Microbiol Clin; 2004 Mar; 22(3):133-7. PubMed ID: 14987532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of famciclovir treatment in chronic hepatitis B patients with different mutations at position 552 of the DNA polymerase gene.
    Wolters LM; Honkoop P; Niesters HG; de Man RA
    J Hepatol; 1998 May; 28(5):909-10. PubMed ID: 9625328
    [No Abstract]   [Full Text] [Related]  

  • 13. Current limitations to nucleoside analogue therapy for chronic hepatitis B virus infection in the liver transplant and non-transplant settings.
    Freiman JS; McCaughan GW
    J Gastroenterol Hepatol; 2000 Mar; 15(3):227-9. PubMed ID: 10764020
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of the efficacy of lamivudine and famciclovir in Asian patients with chronic hepatitis B: results of 24 weeks of therapy.
    Lai CL; Yuen MF; Hui CK; Garrido-Lestache S; Cheng CT; Lai YP
    J Med Virol; 2002 Jul; 67(3):334-8. PubMed ID: 12116023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-mediated immune responses and loss of hepatitis B e-antigen (HBeAg) during successful lamivudine and famciclovir combination therapy for chronic replicating hepatitis B virus infection.
    Hultgren C; Weiland O; Milich DR; Sällberg M
    Clin Infect Dis; 1999 Dec; 29(6):1575-7. PubMed ID: 10585820
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of famciclovir in the treatment of lamivudine resistance related to an atypical hepatitis B virus mutant.
    Tang S; Ho SK; Moniri K; Lai KN; Chan TM
    Transplantation; 2002 Jan; 73(1):148-51. PubMed ID: 11792996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroconversion after the addition of famciclovir therapy in a child with hepatitis B virus infection after liver transplantation who developed lamivudine resistance.
    Shapira R; Daudi N; Klein A; Shouval D; Mor E; Tur-Kaspa R; Dinari G; Ben-Ari Z
    Transplantation; 2002 Mar; 73(5):820-2. PubMed ID: 11907436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy.
    Yeo W; Steinberg JL; Tam JS; Chan PK; Leung NW; Lam KC; Mok TS; Johnson PJ
    J Med Virol; 1999 Nov; 59(3):263-9. PubMed ID: 10502254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How will we use the new antiviral agents for hepatitis B?
    Perrillo RP
    Curr Gastroenterol Rep; 2002 Feb; 4(1):63-71. PubMed ID: 11825543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early detection of viral resistance by determination of hepatitis B virus polymerase mutations in patients treated by lamivudine for chronic hepatitis B.
    Nafa S; Ahmed S; Tavan D; Pichoud C; Berby F; Stuyver L; Johnson M; Merle P; Abidi H; Trépo C; Zoulim F
    Hepatology; 2000 Nov; 32(5):1078-88. PubMed ID: 11050059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.